Exegenesis Overview
- Year Founded
-
2019
- Status
-
IPO Registration
- Employees
-
65
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
11
Exegenesis General Information
Description
Developer of genetic medicines and oligo-based modalities intended for targeted delivery. The company mainly focuses on the research and development of gene therapy drugs and provides a unique gene therapy platform for a variety of major genetic diseases, enabling clients to receive effective treatment for genetic diseases.
Contact Information
Website
www.exegenesisbio.comCorporate Office
- Rooms 301, 302, 401, and 402, Building 11
- Hexiang Technology Center, Qiantang New District
- Hangzhou, Zhejiang
- China
Corporate Office
- Rooms 301, 302, 401, and 402, Building 11
- Hexiang Technology Center, Qiantang New District
- Hangzhou, Zhejiang
- China
Exegenesis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. IPO | 20-Jan-2026 | Announced | Generating Revenue | |||
| 5. Early Stage VC (Series B2) | 04-Jun-2021 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B1) | 29-Dec-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 03-Aug-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A2) | 29-May-2020 | $5.6M | $11.3M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A1) | 16-Aug-2019 | $5.65M | $5.65M | Completed | Generating Revenue |
Exegenesis Signals
Exegenesis Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CPE Funds Management | PE/Buyout | Minority | ||
| Lake Bleu Capital | Hedge Fund | Minority | ||
| Temasek Holdings | Sovereign Wealth Fund | Minority | ||
| Hillhouse Investment Group | PE/Buyout | Minority | ||
| LYFE Capital | PE/Buyout | Minority |
Exegenesis FAQs
-
When was Exegenesis founded?
Exegenesis was founded in 2019.
-
Where is Exegenesis headquartered?
Exegenesis is headquartered in Hangzhou, China.
-
What is the size of Exegenesis?
Exegenesis has 65 total employees.
-
What industry is Exegenesis in?
Exegenesis’s primary industry is Drug Discovery.
-
Is Exegenesis a private or public company?
Exegenesis is a Private company.
-
What is Exegenesis’s current revenue?
The current revenue for Exegenesis is .
-
How much funding has Exegenesis raised over time?
Exegenesis has raised $134M.
-
Who are Exegenesis’s investors?
CPE Funds Management, Lake Bleu Capital, Temasek Holdings, Hillhouse Investment Group, and LYFE Capital are 5 of 11 investors who have invested in Exegenesis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process